Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Horizon Pharma Inc.
Focuses on rapid development of prescription drugs for mild to moderate pain relief
Deerfield, IL
Contact:
Jeff Himawan
www.horizonpharma.com
Formerly Known As: Horizon Therapeutics
Acquisition
Acquired by: Rival Raptor
Exit date: September 16, 2016
Related News
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO® and Provides 2014 Guidance
Horizon Pharma Announces $50.8 Million Private Placement
Venture Firms Offer to Invest in Revamped Horizon Pharma IPO
Horizon Pharma Announces Third Quarter 2013 Financial Results, Reports Net Revenue of $26.2 Million